In animal research, Noopept may increase alpha waves in the brain similarly to the function of Piracetam; however, Noopept also increases beta waves and decreases delta waves. In animals, Noopept is believed to work with acetylcholine and neurotrophin in the brain, although it is not entirely understood
N-Phenylacetyl-L-prolylglycine ethyl ester is promoted as a nootropic and is a prodrug of cycloprolylglycine.
Other names include the brand name Noopept (Russian: Ноопепт), developmental code GVS-111; proposed INN omberacetam.
Its synthesis was first reported in 1996.
Päckchen (je 2g)